Copied


Marvell Technology (MRVL) Stock Price Prediction: Sharp selloff tests support as analysts split on Lumentum deal fallout

Rebeca Moen   Nov 20, 2026 09:11 0 Min Read


Price action and what changed

Marvell Technology (MRVL) closed at $134.89, down 10.96% over 24 hours, with the session trading between $154.80 and $131.74. That puts the stock below its 7-day SMA of $146.89, 20-day SMA of $154.44, and 50-day SMA of $210.09, which is a clear bearish alignment and a sign that the recent move has extended well beyond a routine pullback.

The volatility backdrop is also elevated. MRVL’s 14-day ATR is $13.01, which means the shares can still move sharply from here even if the broader trend stabilizes. Trading volume in Binance futures was $139.3 million, while the volume-price regime versus the 5-day average sits at 0.48x, consistent with a low-volume pullback rather than a panic spike.

Technical structure: oversold, but not yet repaired

Momentum is weak, though not in full capitulation territory. The 14-period RSI is 33.50, which is near oversold but still inside neutral territory. The stochastic readings are deeply depressed, with %K at 7.21 and %D at 5.77, reinforcing that price is stretched on the downside.

MACD is negative at -18.2910, with the signal line also at -18.2910 and the histogram at 0.0000. That leaves the momentum picture flat-to-bearish, not yet showing a clean reversal signal. The stock is also trading near the lower Bollinger Band at $123.01, with %B at 0.1882, so the current zone is close to technical support rather than a reclaimed trend.

Key levels matter here. Immediate support is $126.15, with strong support at $117.42. On the upside, the first hurdle is $140.48 at the pivot point, then $149.21 at immediate resistance, and $163.54 as strong resistance. A sustained recovery needs MRVL to reclaim the pivot first; until then, rallies risk being treated as reflex bounces inside a broader downtrend.

Analyst reaction and company context

The recent catalyst is Marvell’s November 2 announcement that it will combine with Lumentum to build what the company described as a broader AI connectivity platform, with expected long-term revenue and margin benefits and more than $1 billion in annual run-rate cost synergies. That deal has since become the center of analyst debate.

On November 3, TD Cowen downgraded Marvell to Hold from Buy and cut its target to $175 from $350, saying the transaction could dilute EPS by a mid-single-digit percentage in 2028 and may land near the peak of an optical mini-cycle. Bank of America also downgraded the shares, according to the same report. RBC Capital kept an Outperform rating but lowered its target to $250 from $425. B. Riley later cut its target to $250 from $275 while maintaining a Buy rating. Stockanalysis.com also cited 43 analysts with a consensus Strong Buy and an average target of $309.14, but that aggregate sits far above the current tape and reflects a broader set of targets than the recent post-deal revisions.

Scenario framework

If MRVL can hold the $126.15 support zone and start reclaiming $140.48, the shares could shift from oversold drift into a mean-reversion rebound. The first test in that case would be the $149.21 area, where prior downside momentum would need to be absorbed.

If $126.15 gives way decisively, the next meaningful reference is $117.42. A clean break there would argue that the market is still pricing in a larger de-rating tied to the acquisition debate and the still-negative moving average stack.

The current setup is not a clean bullish reversal, but it is stretched enough that any stabilization around support could trigger a sharp technical bounce. The burden of proof is now on buyers: until MRVL reclaims the pivot and short-term averages, the path of least resistance remains lower.


Read More